Objective: To develop a clinically and methodologically sound approach to diagnostic meta-analysis. Methods: Two-step model was used involving four ctitious sets of 10 studies each with varying 48
S ystematic reviews and meta-analyses have emerged as an important branch of biomedical research. They are considered to provide the best scienti c evidence to support or to reject the use of certain interventions and to acknowledge prognostic, aetiological and risk factors of a particular condition or disease. Whereas the terms "systematic review" and "meta-analysis" are often used synonymously, the latter should mainly be regarded as a statistical technique to quantify and to summarise the information provided by a thorough systematic review of published and unpublished studies.
The major goals of meta-analysis are to display the range of effect sizes of individual investigations and to compile these data into some measure of overall ef cacy that can be uniformly interpreted and communicated (which means that audiences with varying background knowledge are able to gain similar information on the topic of interest). These basic requirements have been met by the established methods of meta-analysis of therapeutic studies.
Results are usually presented graphically by means of a forest plot, which gives an excellent impression of the dispersion of effect sizes. The common point estimates, such as odds ratios (OR), relative risks (RR) and risk differences (RD), in combination with their related 95% or 99% con dence intervals, allow clear inferences to be drawn from the available data: the experimental arm fares better, fares equivocally (there is no evidence of a difference) or fares worse than the control arm.
The problem that occurs in a meta-analysis of diagnostic studies is the multidirectional performance of the diagnostic instrument regarding its ability to detect (speci city) or to exclude (sensitivity) the characteristic of interest. Multidimensional outcomes cannot be summarised well by a single estimate. The results gained from a diagnostic test will increase or decrease the probability of there being disease in the presence of certain signs, symptoms and other test results; this is often referred to as Bayes' theorem. 1 In diagnostics, the ability of a test to revise the prior probability of disease is summarised by the likelihood ratio. The likelihood ratio is the likelihood that a given test result will be observed in a patient with the target disorder compared with the likelihood that the same result will be observed in a patient without the target disorder. 2 The positive likelihood ratio is the ratio between the chance of a positive test result in the presence of the characteristic under investigation and the chance of a positive result in the absence of this attribute. For example, a positive likelihood ratio of 4.0 means that a positive test result is four times more likely in a diseased subject than in a healthy person. Likewise, the negative likelihood ratio represents the ratio between the chance of a negative test result in the absence of the characteristic under investigation and the chance of a negative result in the presence of this attribute. Given the positive and the negative likelihood ratio of a test procedure and a certain prevalence, or prior disease probability, the related probability of disease can easily be obtained from nomograms. 2, 3 By convention, marked changes in prior disease probability can be assumed in positive likelihood ratios exceeding 10.0 and negative likelihood ratios below 0.1. 4, 5 The scienti c background for these somewhat arbitrary thresholds can be found in Bayesian decision theory: "classical" signi cance levels often correspond to still substantial posterior probabilities of the null hypothesis of "no change in prior belief". For instance, a p value of 0.05 (which would normally support rejection of the assumption of a null effect) can still correspond to a 52% posterior probability of the null hypothesis. 6 sensitivity and speci city; this was followed by the application of the method to data from a published systematic review of emergency ultrasound. Multidimensional test characteristics (relating to the detection or exclusion of the condition of interest) were described by likelihood ratio scatterplots and pooled likelihood ratios. Likelihood ratios summarise the ability of a test to revise the prior probability of disease. They can be summarised by established xed-effects and random-effects methods.
Results: Likelihood ratios precisely describe both directions of test performance. By plotting positive against negative likelihood ratios, together with their 95% con dence intervals, a multidimensional forest plot is obtained that can be interpreted in analogy to therapeutic meta-analyses. There are accepted threshold values of positive and negative likelihood ratios (i.e. 10.0 and 0.1) to recommend a test for clinical use. In the matrix space, distinct test characteristics can even be assessed by eyeballing. With regard to data from the real meta-analysis, the suggested high discriminatory power of ultrasound was only partially quali ed by likelihood ratios. The positive value con rms the reliability of a positive scan, whereas the negative value questions a normal sonogram.
Conclusions: A full characterisation of test performance requires multidimensional effect measures.
Likelihood ratios are recommended descriptors of the two dimensions of diagnostic research evidence and provide a convenient means to visualise and to communicate results as weighted summary estimates of a diagnostic meta-analysis. 
For the purpose of this study we stress only that an investigation of a certain medical intervention must provide a large amount of additional information to change prior knowledge. Since no threshold values of sensitivity or speci city are available that would allow either the adoption or the rejection of the routine application of a diagnostic procedure, likelihood ratios appear as preferable indices of test performance, at least in the setting of clinical decision-making.
In this investigation we were interested in how likelihood ratios can be used to conduct a diagnostic meta-analysis. Our objectives were to develop a clearly arranged graphical presentation of the results from individual diagnostic studies, and to obtain a summary measure of diagnostic test ef cacy by reasonable computational efforts.
METHODS

Basic considerations
The results of a diagnostic test with a dichotomous outcome can be easily summarised in a 2 ´2 table. Sensitivity (SN, the number of true positives divided by all test positives) and speci city (SP, the number of true negatives divided by all test negatives) are well known characteristics of a diagnostic intervention. Knowledge of both indices is required to appraise test precision fully. However, one might think of clinical situations in which only one of these characteristics is of real interest. For example, the Ottawa ankle rules provide 99% SN to exclude ankle fractures, whereas a 99% SP of transcranial Doppler sonography allows detection of vasospasm in the middle cerebral artery. 7, 8 Many attempts have been made to calculate a single summary statistic from a set of 2 ´2 tables; this statistic is often referred to as the "diagnostic odds ratio". In fact, the application of a diagnostic test always yields two odds ratios: the prior odds will be increased with positive test ndings (leading to an odds ratio ranging from 1 to in nity) and will be decreased if the test turns out negative (with an odds ratio between 0 and 1).
Multidimensional forest plots
The ef cacy of a diagnostic test is precisely characterised by its positive and its negative likelihood ratio in both qualitative (the vector of test performance) and quantitative (the size of this vector) terms.
A test set of four different meta-analytic scenarios was constructed, comprising 10 ctitious studies of identical size (n = 2485). The studies included in these meta-analyses showed the possible combinations of test characteristics: a test of high SN and SP; a test of low SN and high SP; a test of high SN and low SP; and a test of low SN and SP.
The individual positive likelihood ratio (LR+) can be expressed as:
The negative likelihood ratio is calculated as:
Positive and negative likelihood ratios were then arranged in a "multidimensional forest plot" together with their 95% con dence intervals. We hypothesised that this method of graphical presentation could be easily interpreted, especially by readers already used to the "classic" forest plots of therapeutic meta-analyses. The discriminating features of a test will be re ected by the localisation of the data cloud within the quadrants of the matrix space, and this in turn will allow a rapid assessment of the potential usefulness of a diagnostic procedure, even by eyeballing.
The basic steps to obtain a summary measure in a metaanalysis are to weight individual effect measures according to their variance and then to divide the sum of the weighted quantities by the sum of weights.
We adopted general inverse-variance weighted xedeffects models to summarise likelihood ratios. [9] [10] [11] [12] [13] In case of statistical heterogeneity, the DerSimonian-Laird randomeffects method was applied to account for both within-study and between-study variance.
In analogy to therapeutic meta-analyses, summary estimates within the matrix space were given prominence over individual results by the use of lled symbols.
Worked example
Focused abdominal sonography for trauma (FAST) is an emergency ultrasound protocol to screen for free intraabdominal uid after blunt injuries. In general, the examination is performed in three or four standard planes to detect uid collections in the perihepatic space (Morrison's pouch), surrounding the spleen, and in the Douglas' spatium. Approximately 20% of all intra-abdominal traumatic lacerations are not accompanied by signi cant haemoperitoneum. In comparisons with other reference standards, such as diagnostic peritoneal lavage (DPL) or helical computed tomography (HCT), the ability of FAST examination to detect or to exclude the underlying visceral lesion remains unclear.
In the meta-analysis, 11 trials were eligible for analysis, with a total of 2819 subjects -they employed ultrasonography to detect organ injury and made comparisons with either DPL or HCT. 14 It was obvious that ultrasound provided extremely high speci city (range 0.84-1.00) but sensitivity was below 90% in nine of the 11 trials. Table 1 all the relevant descriptive statistics of the studies included in the nal model. Figure 1 shows the distribution of the ctitious data on a scatterplot diagram. The matrix presentation enables a quick visual impression of the strengths and the weaknesses of a diagnostic test in either direction. Tests with excellent discriminatory properties will be plotted to the upper right corner of the matrix space (i.e. exceeding the 10.0 and 0.1 threshold levels), whereas almost useless tests can be found in the lower left quadrant (in other words, in the southwestern edge of the diagram).
RESULTS
Fictitious studies
With regard to the ctitious sample of trials with high SN and poor SP, their expression as likelihood ratios indicates that the majority of studies support the validity of negative test results, whereas uncertainty reigns for positive ndings.
In this example, high SN and poor SP translates to a positive summary likelihood ratio of 1.44 (which means virtually no change in the prior disease probability in the presence of positive results) and a negative likelihood ratio of 0.07 (indicating suf cient power to exclude the presence of disease in negative ndings). Figure 2 illustrates the dispersion of effect sizes observed in the FAST meta-analysis in the scatterplot matrix. The discriminatory power of FAST can be divided into its two components by plotting the positive against the negative likelihood ratios. By including the 95% con dence intervals, we are able to localise the weight of the data cloud, as well as its outliers. Studies with large variance and wide con dence intervals will contribute less to the overall weight than studies with more precise estimates. Obviously, FAST has complex characteristics. As already indicated by the scope of the data cloud, the relaxed combined estimate of the positive likelihood ratio (as derived from the random-effects model) of this meta-analysis is 25.03, with its associated 95% con dence interval ranging from 11.74 to 53.35. This considerably exceeds the above-mentioned threshold level, and positive ultrasound ndings should substantially in uence the prior probability of the presence of organ lacerations.
Worked example
The corresponding negative summary likelihood ratio is estimated at 0.22 (95% con dence interval 0.15-0.33). This translates to a fourfold increased chance of normal ultrasound ndings in the absence of intra-abdominal lesions (compared with the chance of a normal scan in the presence of organ injuries) or a moderate to minor expectation of a negative FAST examination.
DISCUSSION
The usefulness of a diagnostic test can be examined in three ways: 15 (1) its ef ciency in discriminating between a diseased and a healthy population (which is expressed in terms of sensitivity and speci city);
(2) its consequences for clinical decision-making;
(3) the outcome related to the medical actions taken on the basis of test ndings.
The proven discriminatory power of a diagnostic test is a prerequisite to investigate patient outcome, and a systematic work-up of all the scienti c information is needed to assure health-care professionals of the properties of tests used in daily practice. Interestingly, there are far more systematic reviews of therapeutic interventions than of diagnostic tests. 16 This discrepancy might relate to dif culties in interpreting diagnostic meta-analyses. lled symbols are weighted summary likelihood ratios ( xed-effects model) with related 95% con dence intervals. Circles = studies with high SN and high SP; diamonds = studies with low SN and low SP; triangles = studies with low SN and high SP; squares = studies with high SN and low SP. In analogy to the "classic" forest plot, test characteristics can be assessed by eyeballing. The threshold values of 10.0 and 0.1 are a useful procedure by which to divide the matrix into four quadrants. One might argue against combining data from studies of diagnostic tests. Obviously, the ndings from such studies will be in uenced by the characteristics and the size of the patient sample, the prevalence of the condition under investigation and the test threshold used; this provides an argument for a description only of the range of data.
The same limitations also apply to meta-analyses of therapeutic studies. By its nature, meta-analysis provides the most probable approximation of a common effect size based on the available data. However, with proper weighting methods and sensitivity analyses, there is no reason why the central estimate gained from individual diagnostic studies should provide different or even less information than the summary measure calculated from a set of therapeutic trials.
The problem of combining different diagnostic studies in a meta-analysis was rst addressed by summary receiver operating characteristics (SROC) curves, proposed by Moses, Shapiro and Littenberg. 17, 18 Regressing the true-positive rates (sensitivity) to their false-positive rates (1 -speci city) visualises the trade-off between sensitivity and speci city, that is, the price in terms of false-positive ndings that must be paid for a reasonable true-positive rate. The SROC approach is the recommended reference standard for diagnostic meta-analysis. 19 As a univariate summary measure, the Q* value was proposed as the point of intersection where sensitivity equals speci city. Q* shows the desirable characteristics of a univariate measure of the overall discriminatory features of a diagnostic test. However, there are some situations in which Q* leads to some misinterpretation.
Using the test set of ctitious studies, it can be shown that Q* hardly distinguishes highly sensitive but unspeci c tests (Q* = 0.70) from worthless procedures (Q* = 0.58). Moreover, tests with poor sensitivity might yield virtually similar Q* values, regardless of their speci city (0.52 and 0.58, respectively) (see Figure 3 ).
If one is concerned about true-positive rates, the SROC suf ciently depicts the range of effect sizes. The associated one-point estimate, Q*, provides some global evidence of test validity but it fails to discriminate tests with singular strengths (or weaknesses) on one aspect of test performance. If one generally doubts the clinical value of a diagnostic test when SN and SP decrease, Q* perfectly meets the minimal requirements of a univariate measure of effectiveness. If not, relying on a single index of test ef cacy risks missing procedures that perform well in one direction but poorly in the other.
Likelihood ratios are helpful in showing both the bipolar and the unipolar weaknesses of a test (as well as its unipolar strengths). In analogy to forest plots, the likelihood ratio scatterplot matrix illustrates the distribution and the centre of effect sizes from a pool of individual studies and allows identi cation of outliers, as well as of studies relevant for sensitivity analyses.
By using established xed-effects and random-effects techniques, likelihood ratios from individual trials can be condensed to a point estimate from diagnostic meta-analysis. Summary likelihood ratios are convenient numerical descriptors that cover both qualitative and quantitative characteristics of test performance. Stengel 
